Romania Stents Market by Type (Coronary Stents, Peripheral Stents, Stent-related, and Implants) and Material (Metallic Biomaterials, Polymers Biomaterials, and Natural Biomaterials): Opportunity Analysis and Industry Forecast, 2019–2026

Medical Devices & Supplies	LI_184853	Pages: NA	Dec 2019 \| 411 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

A stent is a wired mesh tube that aids in keeping coronary arteries open and reduce the risk of a heart attack due to fat deposits in the arteries. They are made of metals, polymers, and natural bioabsorbable materials. They enhance various surgical procedures such as angioplasty or percutaneous coronary intervention (PCI). Moreover, they regulate the blood supply to the heart and are mostly made up of stainless steel. They are implanted in the esophagus to enable the passage of food and beverages in patients suffering from esophageal cancer. In addition, they are inserted in the ureter to prevent obstruction of urine flow from kidney, in the gall bladder to allow passage of bile in patients suffering from gall bladder cancer, and in the abdomen & gastrointestinal tract.

The factors such as increase in usage of stents in minimally invasive surgical procedures and surge in geriatric population in Romania prone to cardiovascular diseases and other chronic ailments fuel the growth of the Romania stents market. For instance, according to European Geriatric Medicine Society, total population of Romania was 21,666,350 in 2015. The percentage of the population aged above 85 years was 1.3% in 2011, and above 65 years was 17% in 2016. Furthermore, , according to Eurostat series, the old age dependency ratio in Romania increased from 21.5 in 2007 to 26.7 in 2017. Moreover, active participation of Romania in initiative taken toward usage of stents boosts the market growth. For instance, Romania is a member of Stent for Life Initiative that ensures the availability of lifesaving indication of primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction patients, which fuels the growth of the Romania stents market. Moreover, companies have shifted their focus on developing technologically advanced stents with the aim of serving a wider audience, thereby propelling the market growth. The coronary stents market trends such as incorporation of micro-sized stents and use of minimally invasive procedures are expected to serve as lucrative opportunities during the forecast period. Furthermore, rise in use of bioresorbable stent, increase in adoption of bifurcated stents, and upsurge in adoption of co-polymers as raw materials are anticipated to provide lucrative opportunities for the market growth across Romania.

However, high cost of treatment associated with stent implants and stringent approval process, as these are highly specialized devices are expected to hinder the market growth.

The Romania stents market is segmented into type and material. Depending on type, the Romania stents market is categorized into coronary stents, peripheral stents and stent-related implants. By material, it is divided into metallic biomaterials, polymers biomaterials and natural biomaterials.

Major players operating in the Romania stents market include Abbott Laboratories, B. Braun Melsungen Ag, Biotronik Se & Co. Kg, Boston Scientific Corporation, C. R. Bard, Inc., Medtronic Plc, Stentys S.A., Terumo Corporation, Microport Scientific Corporation, and Elixir Medical Corporation.

KEY BENEFITS FOR STAKEHOLDERS

This report provides a detailed quantitative analysis of the current Romania stents market trends and forecast estimations from 2019 to 2026, which assist to identify the prevailing market opportunities.
An in-depth market analysis includes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the market is provided.
The projections in this report are made by analyzing the current market trends and future market potential from 2019 to 2026 in terms of value.
An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which help to understand the competitive outlook of market.

KEY MARKET SEGMENTS

By Type

Coronary Stents
Peripheral Stents
Stent-related Implants

By Material

Metallic Biomaterials
Polymers Biomaterials
Natural Biomaterials

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PTCA PROCEDURES IN ROMANIA
3.4. AVERAGE SELLING PRICE OF STENTS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

CHAPTER 4 ROMANIA STENTS MARKET, BY TYPE

4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. CORONARY STENTS
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast
4.2.3. Drug-Eluting Stents (DES)
4.2.3.1. Key market trends, growth factors and opportunities
4.2.3.2. Market size and forecast
4.2.4. Bare-Metal Coronary Stents
4.2.4.1. Key market trends, growth factors and opportunities
4.2.4.2. Market size and forecast
4.2.5. Bioabsorbable Stents
4.2.5.1. Key market trends, growth factors and opportunities
4.2.5.2. Market size and forecast
4.3. PERIPHERAL STENTS
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast
4.3.3. Iliac
4.3.3.1. Key market trends, growth factors and opportunities
4.3.3.2. Market size and forecast
4.3.4. Femoral-Popliteal
4.3.4.1. Key market trends, growth factors and opportunities
4.3.4.2. Market size and forecast
4.3.5. Renal
4.3.5.1. Key market trends, growth factors and opportunities
4.3.5.2. Market size and forecast
4.3.6. Carotid
4.3.6.1. Key market trends, growth factors and opportunities
4.3.6.2. Market size and forecast
4.4. STENT-RELATED IMPLANTS
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast
4.4.3. Synthetic Grafts
4.4.3.1. Key market trends, growth factors and opportunities
4.4.3.2. Market size and forecast
4.4.4. Vena Cava Filters
4.4.4.1. Key market trends, growth factors and opportunities
4.4.4.2. Market size and forecast

CHAPTER 5 ROMANA STENTS MARKET, BY MATERIAL

5.1. OVERVIEW
5.2. METALLIC BIOMATERIALS
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast
5.3. POLYMERS BIOMATERIALS
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast
5.4. NATURAL BIOMATERIALS
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1. ABBOTT LABORATORIES
6.1.1. Operating business segments
6.1.2. Business performance
6.1.3. Key strategic moves and developments
6.2. B. BRAUN MELSUNGEN AG
6.2.1. Operating business segments
6.2.2. Business performance
6.2.3. Key strategic moves and developments
6.3. BIOTRONIK SE & CO. KG
6.3.1. Operating business segments
6.3.2. Business performance
6.3.3. Key strategic moves and developments
6.4. BOSTON SCIENTIFIC CORPORATION
6.4.1. Operating business segments
6.4.2. Business performance
6.4.3. Key strategic moves and developments
6.5. C. R. BARD, INC.
6.5.1. Operating business segments
6.5.2. Business performance
6.5.3. Key strategic moves and developments
6.6. MEDTRONIC PLC
6.6.1. Operating business segments
6.6.2. Business performance
6.6.3. Key strategic moves and developments
6.7. STENTYS S.A.
6.7.1. Operating business segments
6.7.2. Business performance
6.7.3. Key strategic moves and developments
6.8. TERUMO CORPORATION
6.8.1. Operating business segments
6.8.2. Business performance
6.8.3. Key strategic moves and developments
6.9. MICROPORT SCIENTIFIC CORPORATION
6.9.1. Operating business segments
6.9.2. Business performance
6.9.3. Key strategic moves and developments
6.10. ELIXIR MEDICAL CORPORATION
6.10.1. Operating business segments
6.10.2. Business performance
6.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,110 Data Pack/Excel ~~$3,840~~ $3,456 Single User License ~~$5,370~~ $4,833 Five User License ~~$6,450~~ $5,805 Enterprise User License ~~$8,995~~ $8,096

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com